Halozyme Therapeutics shares owned by LSV Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by LSV Asset Management
from 13F filings
Historical chart of LSV Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by LSV Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by LSV Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $93M | 1.3M | 73.34 |
| 2025-06-30 | $65M | 1.3M | 52.02 |
| 2025-03-31 | $57M | 895k | 63.81 |
| 2024-12-31 | $30M | 631k | 47.81 |
| 2024-09-30 | $36M | 631k | 57.24 |
| 2024-06-30 | $32M | 614k | 52.36 |
| 2024-03-31 | $19M | 462k | 40.68 |
| 2023-12-31 | $17M | 462k | 36.96 |